Therapy News and Research

RSS

Researchers reveal potential new role for Glivec/Imatinib

Imatinib – or Glivec as it also known – looks as if it may become an effective treatment for yet another type of cancer.

28 Sep 2004

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Arsenic trioxide – a highly poisonous substance best known as an effective weed killer or pesticide and notorious for being a favourite ‘weapon’ of choice in murder mystery novels, is being re-invented as a treatment for a rare type of leukaemia.

28 Sep 2004

New guidelines for the treatment of patients with stroke and TIA

New guidelines launched today aim to help primary care teams deliver effective treatment and secondary prevention to stroke patients.

28 Sep 2004

New hope for patients suffering hormone therapy resitant prostate cancer

New hope was offered today to men with advanced prostate cancer that no longer responds to hormone therapy – a persistent problem in prostate cancer treatment.

27 Sep 2004

Active ingredients of soya may help beat breast cancer

Researchers are investigating whether it is possible to turn the active ingredients of soya into a useful medicine that may help to beat breast cancer, the British Pharmaceutical Conference heard today.

27 Sep 2004

New methods for the growth and development of human pancreatic beta islets

Vitro Diagnostics has announced the development of new methods for the growth and development of human pancreatic beta islets (Islets of Langerhans) and the filing of a new patent application with the United States Patent and Trademark Office.

27 Sep 2004

Researchers have integrated heart cells grown from human embryonic stem cells into a host heart

Researchers at the Technion-Israel Institute of Technology and Rambam Medical Center have demonstrated that heart cells grown from human embryonic stem cells can integrate into the host heart and help regulate its activity, becoming in effect a biological pacemaker.

27 Sep 2004

Pregnant women are at higher risk for restless legs syndrome

Pregnant women are at higher risk for the occurrence or worsening of restless legs syndrome (RLS), a movement disorder that affects up to 10 percent of the general population, according to a study reported in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

27 Sep 2004

Group therapy does not improve survival in early-stage breast cancer patients

A new study shows that cognitive-existential group therapy (CEGT), a psychosocial intervention designed to improve the mood and attitude of patients with breast cancer, does not improve survival of women with early-stage disease.

27 Sep 2004

Discovery of key molecular step which allows cancer cells to move to different parts of the body

Researchers at The University of Texas M. D. Anderson Cancer Center have figured out a key molecular step by which a cancer cell can unhook itself from the mesh weave of other cancer cells in a tumor, and move away to a different part of the body - the process, known as metastasis, that makes cancer so dangerous.

27 Sep 2004

Chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer

A new study finds chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer (cancer that has not spread beyond the ovary). But it remains unclear which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.

27 Sep 2004

Palladone approved for pain relief

The Food and Drug Administration (FDA) has approved Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous around-the-clock opioid pain relief for an extended period of time.

26 Sep 2004

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

Researchers first gave the drug, mannitol, to provide temporary passage through the blood-brain barrier then transfused human umbilical cord blood cells into a stroke animal model. When used in the first hours and days following a stroke, stroke size decreased by 40 percent and resulting disability was significantly reduced.

26 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

Therapy News and Research

Researchers reveal potential new role for Glivec/Imatinib

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

New guidelines for the treatment of patients with stroke and TIA

New hope for patients suffering hormone therapy resitant prostate cancer

Active ingredients of soya may help beat breast cancer

New methods for the growth and development of human pancreatic beta islets

Researchers have integrated heart cells grown from human embryonic stem cells into a host heart

Pregnant women are at higher risk for restless legs syndrome

Group therapy does not improve survival in early-stage breast cancer patients

Discovery of key molecular step which allows cancer cells to move to different parts of the body

Chemotherapy improves survival and reduces the risk of recurrence in women with stage I ovarian cancer

Palladone approved for pain relief

Stem cells from umbilical cord blood, given intravenously with mannitol drug reduce stroke size and damage

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

$16 million investment in minute wireless implant technology

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

Pneumonia could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin

Physiotherapy no better than advice for back pain

Research may lead to alternatives to antibiotic drugs for treating bacterial diseases

Potential new way to control drug-resistant bacteria

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News